Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Celgene seeds PharmAria, commits to future funding and collaboration

Executive Summary

Celgene Corp. has provided an undisclosed amount of seed funding to help new cancer and fibrotic disease therapeutics company PharmAria LLC get off the ground. The biotech has also said it will participate in the start-up’s Series A round for a possible equity stake, potentially license certain R&D works, and later could take an option to acquire the company outright.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register